Novel antibiotic candidates starve resistant bacteria by blocking vitamin supply

Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland have developed synthetic drug candidates that starve bacteria by blocking their vitamin supply. These molecules target energy-coupling factor transporters, which are absent in human cells, potentially reducing side effects.
Why it matters
This discovery offers a promising new strategy to combat antibiotic-resistant bacteria, a growing global health crisis.
by Andreas Fischer, Helmholtz Association of German Research Centres
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source HIPS researchers identify novel targets for antibiotics. Credit: HIPS/Lucia Bernhardt Bacteria have spent decades evolving resistance to virtually every antibiotic we have thrown at them. To stay ahead, new drugs must hit targets that existing antibiotics have never touched. A research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a series of synthetic drug candidates that do exactly that: By blocking an essential molecular supply system, these molecules cut off the bacteria's supply of essential vitamins and starve them to death. The team published its findings in two studies in the Journal of Medicinal Chemistry .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in